Balance Sheet - Entrada Therapeutics, Inc. (TRDA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 295.70 | 420.00 | 351.97 | 188.71 | 291.06 | 39.05 | 16.84 |
| Accounts receivable, net | 3.68 | 5.88 | 0.87 | ||||
| Inventories | 0.00 | ||||||
| Other current assets | 10.55 | 16.36 | 11.92 | 21.16 | 7.64 | 0.90 | 0.59 |
| Total current assets | 306.25 | 440.04 | 369.77 | 209.88 | 298.70 | 39.95 | 17.44 |
| Total non-current assets | 71.13 | 86.28 | 99.42 | 42.18 | 7.13 | 3.58 | 0.80 |
| Total assets | 377.38 | 526.32 | 469.19 | 252.06 | 305.83 | 43.53 | 18.24 |
| Total current liabilities | 24.45 | 39.48 | 158.80 | 21.97 | 6.72 | 3.36 | 1.92 |
| Total non-current liabilities | 46.79 | 58.16 | 68.04 | 17.53 | 0.40 | 81.66 | 31.84 |
| Total liabilities | 71.25 | 97.64 | 226.83 | 39.50 | 7.12 | 85.02 | 33.76 |
| Total stockholders' equity | 306.13 | 428.68 | 242.36 | 212.55 | 298.72 | -41.49 | -15.52 |
| Common shares outstanding | 41 | 39 | 33 | 31 | 31 | 31 | 1 |
Show Quarterly Balance Sheet
Balance Sheet - Entrada Therapeutics, Inc. (TRDA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 254.86 | 295.70 | 326.84 | 354.01 | 382.52 | 420.00 | 449.34 | 469.75 | 327.41 | 351.97 | 353.58 | 376.79 | 411.63 | 188.71 | 215.57 | 244.25 | 263.90 | 291.06 | 122.17 | 136.95 | 39.05 | 39.05 | 0.00 | 0.00 | 16.84 |
| Accounts receivable, net | 3.20 | 1.18 | 2.04 | 3.68 | 2.60 | 7.67 | 77.51 | 5.88 | 5.03 | 3.74 | 6.30 | 0.87 | 2.97 | ||||||||||||
| Inventories | -3.80 | 0.00 | 0.00 | -5.03 | 183.98 | ||||||||||||||||||||
| Other current assets | 12.01 | 10.55 | 8.22 | 13.95 | 18.63 | 16.36 | 13.39 | 12.12 | 9.24 | 11.92 | 24.44 | 9.66 | 16.21 | 21.16 | 19.16 | 9.65 | 8.81 | 7.64 | 1.35 | 0.69 | 0.90 | ||||
| Total current assets | 266.87 | 306.25 | 338.26 | 369.15 | 403.19 | 440.04 | 465.34 | 489.54 | 414.17 | 369.77 | 383.04 | 390.20 | 434.14 | 209.88 | 234.73 | 253.90 | 272.71 | 298.70 | 123.53 | 137.64 | 39.05 | 39.95 | 16.84 | ||
| Total non-current assets | 68.65 | 71.13 | 74.64 | 79.64 | 83.29 | 86.28 | 89.26 | 92.43 | 96.67 | 99.42 | 101.99 | 103.79 | 41.43 | 42.18 | 39.73 | 42.01 | 43.99 | 7.13 | 8.87 | 5.88 | -39.05 | 3.58 | -16.84 | ||
| Total assets | 335.52 | 377.38 | 412.90 | 448.78 | 486.48 | 526.32 | 554.59 | 581.96 | 510.84 | 469.19 | 485.03 | 493.98 | 475.57 | 252.06 | 274.46 | 295.92 | 316.70 | 305.83 | 132.40 | 143.51 | 43.53 | ||||
| Total current liabilities | 19.20 | 24.45 | 24.02 | 19.80 | 18.43 | 39.48 | 70.60 | 85.81 | 173.94 | 158.80 | 165.43 | 125.94 | 147.59 | 21.97 | 21.55 | 18.08 | 15.43 | 6.72 | 7.16 | 4.54 | 4.54 | 3.36 | |||
| Total non-current liabilities | 45.47 | 46.79 | 48.16 | 49.48 | 50.79 | 58.16 | 61.54 | 66.23 | 67.54 | 68.04 | 72.94 | 161.14 | 98.36 | 17.53 | 19.69 | 21.80 | 23.89 | 0.40 | 197.83 | 197.99 | -40.17 | 81.66 | -16.30 | ||
| Total liabilities | 64.66 | 71.25 | 72.18 | 69.28 | 69.22 | 97.64 | 132.14 | 152.04 | 241.48 | 226.83 | 238.37 | 287.08 | 245.96 | 39.50 | 41.24 | 39.88 | 39.31 | 7.12 | 204.99 | 202.53 | -40.17 | 85.02 | -16.30 | ||
| Total stockholders' equity | 270.85 | 306.13 | 340.72 | 379.51 | 417.26 | 428.68 | 422.45 | 429.93 | 269.37 | 242.36 | 246.66 | 206.91 | 229.61 | 212.55 | 233.22 | 256.04 | 277.39 | 298.72 | -72.59 | -59.01 | 40.17 | -41.49 | 16.30 | ||
| Common shares outstanding | 42 | 41 | 41 | 41 | 41 | 43 | 41 | 36 | 35 | 33 | 35 | 33 | 32 | 31 | 31 | 31 | 31 | 21 | 28 | 20 | 20 | 20 | 20 | 1 | 1 |